GB Sciences, Inc. (GBLX)
OTCMKTS: GBLX · Delayed Price · USD
0.0085
+0.0014 (19.72%)
Jul 26, 2024, 9:40 AM EDT - Market closed
GB Sciences Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Year Ending | TTM | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | 2017 - 2012 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 3.45 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | 37.61% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 3.25 | Upgrade
|
| Gross Profit | - | - | - | - | - | 0.21 | Upgrade
|
| Selling, General & Admin | 1.09 | 1.18 | 1.05 | 1.65 | 5.74 | 13.4 | Upgrade
|
| Research & Development | 0.49 | 0.49 | 0.82 | 0.35 | - | - | Upgrade
|
| Operating Expenses | 1.58 | 1.67 | 1.87 | 2 | 5.74 | 13.4 | Upgrade
|
| Operating Income | -1.58 | -1.67 | -1.87 | -2 | -5.74 | -13.19 | Upgrade
|
| Interest Expense | -0.18 | -0.18 | -0.47 | -1.29 | -1.11 | -4.94 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.42 | 0.1 | 0.01 | -0.65 | -0.18 | -0.23 | Upgrade
|
| EBT Excluding Unusual Items | -1.34 | -1.75 | -2.33 | -3.94 | -7.03 | -18.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 5.19 | - | 4.39 | - | Upgrade
|
| Asset Writedown | -2.42 | -2.37 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -3 | 0.6 | -2.11 | -3.14 | Upgrade
|
| Pretax Income | -3.76 | -4.13 | -0.15 | -3.33 | -4.75 | -21.5 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | 0.53 | Upgrade
|
| Earnings From Continuing Operations | -3.76 | -4.13 | -0.15 | -3.33 | -4.75 | -22.03 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -0.38 | -0.39 | -8.36 | -2.65 | Upgrade
|
| Net Income to Company | -3.76 | -4.13 | -0.53 | -3.73 | -13.11 | -24.68 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0.74 | 1.03 | Upgrade
|
| Net Income | -3.76 | -4.13 | -0.53 | -3.73 | -12.37 | -23.65 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.27 | - | - | - | - | - | Upgrade
|
| Net Income to Common | -4.03 | -4.13 | -0.53 | -3.73 | -12.37 | -23.65 | Upgrade
|
| Shares Outstanding (Basic) | 390 | 358 | 318 | 285 | 258 | 210 | Upgrade
|
| Shares Outstanding (Diluted) | 390 | 358 | 318 | 285 | 258 | 210 | Upgrade
|
| Shares Change (YoY) | 13.82% | 12.62% | 11.37% | 10.35% | 23.34% | 57.63% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.00 | -0.01 | -0.05 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.00 | -0.01 | -0.05 | -0.11 | Upgrade
|
| Free Cash Flow | -0.94 | -1.53 | -1.87 | -2.19 | -4.48 | -11.37 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 | -0.05 | Upgrade
|
| Gross Margin | - | - | - | - | - | 6.03% | Upgrade
|
| Operating Margin | - | - | - | - | - | -381.85% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -329.07% | Upgrade
|
| EBITDA | -1.58 | -1.61 | -1.8 | -1.95 | -5.62 | -12.94 | Upgrade
|
| D&A For EBITDA | 0 | 0.06 | 0.07 | 0.05 | 0.13 | 0.25 | Upgrade
|
| EBIT | -1.58 | -1.67 | -1.87 | -2 | -5.74 | -13.19 | Upgrade
|
Source: S&P Capital IQ. Standard template.